000 01247 a2200301 4500
005 20250516212323.0
264 0 _c20150127
008 201501s 0 0 eng d
022 _a1432-1440
024 7 _a10.1007/s00109-014-1161-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLeto, Simonetta M
245 0 0 _aPrimary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies.
_h[electronic resource]
260 _bJournal of molecular medicine (Berlin, Germany)
_cJul 2014
300 _a709-22 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aBiomarkers, Tumor
_xmetabolism
650 0 4 _aColorectal Neoplasms
_xdrug therapy
650 0 4 _aDrug Resistance, Neoplasm
650 0 4 _aHumans
650 0 4 _aProtein-Tyrosine Kinases
_xantagonists & inhibitors
700 1 _aTrusolino, Livio
773 0 _tJournal of molecular medicine (Berlin, Germany)
_gvol. 92
_gno. 7
_gp. 709-22
856 4 0 _uhttps://doi.org/10.1007/s00109-014-1161-2
_zAvailable from publisher's website
999 _c23809696
_d23809696